DOTA-PSMA-EB-01 (Compound LNC1003) is a specific inhibitor of PSMA with an IC50 of 10.77 nM. It enhances tumor uptake and retention of 177Lu. DOTA-PSMA-EB-01 is applicable in the synthesis or research of radiolabeled conjugates (RDC).
Formula:
C87H115N15O28S2
Target:
PSMA
* VAT and and shipping costs not included. Errors and price changes excepted
